U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07228221) titled 'Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma' on Nov. 13.
Brief Summary: The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.
Study Start Date: Jan. 05, 2026
Study Type: INTERVENTIONAL
Condition:
Open Angle Glaucoma
Pigmentary Glaucoma
Pseudoexfoliation Glaucoma
Intervention:
DEVICE: iStent infinite trabecular micro-by...